FDA Inspection 1170199 — Philips Respironics, Inc.

Philips Respironics, Inc. — FEI 2518422

The FDA completed an inspection of Philips Respironics, Inc. on May 19, 2022 in Murrysville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 19, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Murrysville, PA (United States)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
313021 CFR 820.100(a)Lack of or inadequate procedures